If you prefer to speak to someone when ordering vaccines our customer service team is available to help you weekdays from 9am to 5pm.

Call us for vaccines ordering on the number below or&nbsp;<a href="https://pro.campus.sanofi/uk/general-topics/articles/contact-vaccines">request a call back</a>.

<a href="https://www.vaxishop.co.uk/vaxishop/en/GBP/login?site=vaxishop&amp;utm_source=campus-way-to-order&amp;utm_medium=website&amp;utm_campaign=qiv-hd&amp;utm_term=text-link" target="_blank">VaxiShop</a>&nbsp;is our simple to use vaccines ordering site.

It allows you to conveniently and efficiently&nbsp;place vaccines orders, set up&nbsp;vaccine standing orders,&nbsp;track deliveries, manage invoices, and view your order history.

Some of our paediatric vaccines are available on the national immunisation programme and can be easily ordered through&nbsp;<a href="https://portal.immform.phe.gov.uk/Logon.aspx?returnurl=%2f">ImmForm</a>.

ImmForm is a UKHSA website which provides vaccine ordering facilities for the national immunisation programme.

<h2>Vaccine Standing Order (VSO) benefits</h2>
Our Vaccine Standing Order (VSO) is tailored to your vaccine requirements to help you place and manage orders with ease, flexibility and peace of mind.&nbsp;
With this in place, you will have priority access to your chosen vaccines at times of the year when you need them most.
It's also easy to update your VSO if requirements change via VaxiShop or by&nbsp;<a href="https://pro.campus.sanofi/uk/general-topics/articles/contact-vaccines">contacting us</a>.

You can easily alter, amend or postpone a delivery, if necessary, to meet your changing vaccine requirements.

You receive a discount per vaccine based on your annual order rather than per delivery for maximum savings.

You can set up recurring orders, manage stock, track deliveries and access regular invoices efficiently online.

As a priority customer your supply will be protected in the event of supply disruption, giving you peace of mind and the confidence to maintain an effective service.

<h2>Flu Vaccines Returns</h2>
We understand that forecasting the number of influenza vaccines you need in any given season is never easy. That's why we offer a&nbsp;"take-back service"&nbsp;giving you peace of mind that&nbsp;a percentage&nbsp;of any Sanofi flu order can be returned free of charge at the end of the flu season if it remains unused in your fridge.&nbsp;

Get in touch with the Vaccines Team

Ways to Order

OTHER-VACCINES-TOPICS

VACCINES

Welcome to your Health System Collaboration Portal. Whether you are focused on population health management, service design or budget planning, you can find here tools to address health inequalities and improve patient outcomes. Get quick access to product information, useful resources from therapy support to treatment guidelines, formulary and service support across various therapy areas.
Our field representatives are here to offer you a personalized support: from improving access to healthcare services to capability building, our team can help design and implement strategies to reduce inequalities in your region.

<h4>Get in touch and discuss with your local representative</h4>

<h4>To unlock content tailored to your locality and receive emails about our products and services</h4>

<h3>Let’s Be Sustainable</h3>
The NHS is one of the world’s first healthcare systems to explicitly put sustainability in its targets which, as a committed NHS partner, we are supporting in numerous ways.

<h3>Formulary and Service Support</h3>
Resources designed to inform, aid and give you a higher level of insight into specific therapy areas, and to help you design and implement strategies to reduce inequalities in healthcare.

Sanofi undertakes collaborative working projects for the benefit of patients and/or the NHS. These projects are entirely non promotional and are not linked in any way to any of our products.

<h3>Let's Be Collaborative and Transformative</h3>
Explore collaborative working case studies and discover how Sanofi has been working in partnership with the NHS to deliver optimised care across the UK.

Get in Touch with the Health System Solutions Team

Health System Collaboration Portal

PAYOR

OUT-OF-TAXONOMY

This section has resources that you may require for your formulary submissions and business cases or policy reviews. As well as product information, therapy support resources and treatment guidelines. You can download these materials to better support your decision making.

Diabetes and Cardiovascular

Vaccines

Dermatology

Oncology

Formulary and Service Support

The NHS is one of the world’s first healthcare systems to explicitly put sustainability in its targets which. As a committed NHS partner, we’re supporting in numerous ways. These include providing carbon reduction plans in our NHS tenders at the same time as tackling climate change and accelerating the reduction of our own environmental impact across the business.​

Sanofi launched the Repen programme in 2024. This pilot programme forms part of Sanofi’s commitment to environmental protection. The used pens are posted back for recycling, free of charge to be recycled into metal, glass and plastic furniture.&nbsp;
Read more on the Repen recycling initiative that saves thousands of tonnes of waste each year.

<h2>How is Sanofi building a sustainable environment?&nbsp;</h2>

Sanofi is working to minimise the impacts of its activities and medicines on the environment through its Planet Care environmental sustainability programme, an approach that engages everyone at Sanofi.

Let’s Be Sustainable

Collaboration with healthcare organisations and the NHS to deliver real value beyond our medicines. Explore different joint working working projects covering a range of disease areas, including diabetes, oncology, dermatology, vaccines and cardiovascular disease that deliver benefits to the patients, healthcare organisations and life sciences companies involved. Whenever possible, we publish the conclusions of our collaborative working so that others can learn from our experiences.

Sanofi undertakes collaborative working projects for the benefit of patients and/or the NHS. These projects are entirely non promotional and are not linked in any way to any of our products.

Transplant

Diabetes

Let’s be Collaborative​ and Transformative

<a href="${link:{uuid:{8e9c1745-d4cd-4c78-a226-f934d2da127e},repository:{dam},path:{/Portal/UK/Prescribing-links/MenQuadfi-PI-GB-June-2023.pdf}}}">MenQuadfiTM</a>▼ <a href="${link:{uuid:{8e9c1745-d4cd-4c78-a226-f934d2da127e},repository:{dam},path:{/Portal/UK/Prescribing-links/MenQuadfi-PI-GB-June-2023.pdf}}}">(meningococcal (group A,C,W,Y) conjugate vaccine)&nbsp;Prescribing Information UK</a>&nbsp; All travellers aged over one year, arriving for Umrah, Hajj or for seasonal work in Hajj zones, are required to submit a valid vaccination certificate with a quadrivalent (ACWY) meningococcal vaccine received at least 10 days prior to the planned arrival to Hajj and Umrah areas.1

TRAVEL

<h2 style="margin-bottom: 14px;">Hajj and Umrah</h2>
Hajj is the annual Islamic pilgrimage to Makkah (Mecca) in the Kingdom of Saudi Arabia (KSA).
<ul>
 <li style="margin-bottom: 14px; margin-left: 8px;">It is attended by approximately 3 million Muslims each year</li>
 <li style="margin-bottom: 14px; margin-left: 8px;">All adult, able-bodied Muslims are required to undertake Hajj at least once in their lifetime if they have the means to do so</li>
 <li style="margin-bottom: 14px; margin-left: 8px;">Umrah is a shorter, non-compulsory pilgrimage for Muslims, which is performed as part of the Hajj ritual, but can also be undertaken at any time.1</li>
 <li style="margin-bottom: 14px; margin-left: 8px;">Hajj occurs between the 8th and 12th day of the twelfth month of the Islamic calendar.</li>
 <li style="margin-bottom: 14px; margin-left: 8px;">In 2025 it is estimated to be from Wednesday, 4th June 2025 - Monday, 9th June</li>
</ul>

Download Certificate of immunisation against meningococcal ACWY serogroups, to give to patients receiving a MenQuadfi vaccination

Order patient materials including Hajj and Umrah patient posters

Hajj and Umrah posters are provided in 4 languages

<h2 style="margin-bottom: 14px;">Healthcare professional checklist for patients who will be attending Hajj or Umrah:</h2>
<a href="${link:{uuid:{47db5948-901d-4fb2-8cf5-be02a49759e6},repository:{products},path:{/UK/menquadfi}}}">Learn more about the Menquadfi product</a>.
<ul style="margin-bottom:14px">
 <li style="margin-bottom:14px; margin-left:8px">Ensure they are up to date on all routine immunisations1</li>
 <li style="margin-bottom:14px; margin-left:8px">Check on their fitness level and ask about any existing medical conditions. Hajj rituals can be taxing.1</li>
 <li style="margin-bottom:14px; margin-left:8px">Remind them to practise good hand hygiene and avoid sharing drinks and eating utensils1
 <ul>
 <li style="margin-bottom:14px; margin-left:8px">Required vaccinations:1</li>
 <li style="margin-bottom: 14px; margin-left: 8px;">COVID-19 – full course</li>
 <li style="margin-bottom: 14px; margin-left: 8px;">MenACWY vaccine received at least 10 days prior to arrival to&nbsp;Umrah areas</li>
 <li style="margin-bottom: 14px; margin-left: 8px;">Polio</li>
 <li style="margin-bottom: 14px; margin-left: 8px;">Yellow Fever</li>
 </ul></li>
</ul>
See the <a href="https://travelhealthpro.org.uk/factsheet/19/hajj-and-umrah" target="_blank">NaTHNaC Travel Health Pro</a> page for further recommended vaccines and other health risks.

<div>
 &nbsp;
</div>
<div>
 &nbsp;
</div>

MenQuadfi▼ (Meningococcal Group A, C, W and Y Conjugate Vaccine) Support resources

MenQuadfi PI UK

<h2>To know more about the diagnostic algorithms for Gaucher disease, please click the relevant link below:</h2>

A diagnostic algorithm for adults of Non&ndash;Ashkenazi Jewish origin

A diagnostic algorithm for adults of Ashkenazi Jewish origin

A diagnostic algorithm for adults with splenomegaly and/or thrombocytopenia

A diagnostic algorithm for paediatric patients

Diagnostic Algorithms for Gaucher disease

GAUCHER

RARE-DISEASE

<h2>Signs and Symptoms of Gaucher disease</h2>
Gaucher disease has similar signs and symptoms to a number of hematological malignances.

Downloadable PDF: Signs & Symptoms of Gaucher disease

Ask us your questions about our products, patient materials or organising a meeting.

Sanofi is here to support you and your patients

<h3>Toujeo® DoubleStar™ 
 (insulin glargine 300 units/mL)</h3>
<a href="${link:{uuid:{f34a87f8-75d0-4459-a2d8-c10d6469758f},repository:{dam},path:{/Portal/UK/Prescribing-links/Toujeo-combined.pdf}}}">Prescribing information</a>

<h3>Toujeo® SoloStar™ 
 (insulin glargine 300 units/mL)</h3>
<a href="${link:{uuid:{f34a87f8-75d0-4459-a2d8-c10d6469758f},repository:{dam},path:{/Portal/UK/Prescribing-links/Toujeo-combined.pdf}}}">Prescribing information</a>

<h3>Lantus® SoloStar™ 
 (insulin glargine 100 units/mL)</h3>
<a href="${link:{uuid:{8f132346-a5c2-470d-8368-64ab56220e08},repository:{dam},path:{/Portal/UK/Prescribing-links/Lantus_GB_NI_PI.pdf}}}">Prescribing information</a>

<h3>Admelog® 
 (insulin lispro 100 units/mL)</h3>
<h3>This is intended for HCPs practising in Great Britain (England, Scotland, Wales) only.</h3>

<h3>Trurapi®▼ 
 (insulin aspart 100 units/mL)</h3>
<h3>This is intended for HCPs practising in Great Britain (England, Scotland, Wales) only.</h3>

Diabetes patient support

TYPE-1-DIABETES

TYPE-2-DIABETES

DIABETES

To read this content, please activate your Sanofi Campus account via the email we've sent to you.

If you didn't receive our first email at {email} to confirm your account you can request a new one below. If you don't see it, you may need to check your spam folder.

title

In order to see relevant content, tell us what you are interested in

Title

This website is for healthcare professionals only.

Welcome to BP Sanofi Campus

Create new password

complete your profile to help us provide you with content that's relevant to you.

Your profile is incomplete

Development of ADCT involved literature review as well as interviews with patients and physicians, and was funded by Sanofi and Regeneron.

The ADCT gives a measure of how controlled your patient’s eczema is. Use these 6 concise questions to evaluate all dimensions of atopic dermatitis control.

Atopic dermatitis, a type of eczema, may be affecting your patient’s life in more ways than you know.

Enjoy more exclusive content{newline}by <a>registering today</a>

MAT-XU-2300297 (v3.0) - Date of preparation: October 2023

MAT-XU-2305062 (v1.0) - Date of preparation: November 2023

MAT-XU-2300297 (v3.0) Date of Preparation: October 2023

MAT-XU-2305047 (v1.0) - Date of preparation: November 2023

Already have an account? <a>Sign in here</a>

Best practices on optimising patient care

Get a customised view of the topics that you're interested in, along with the ability to save content to watch or read at a later date.

Unlimited access to premier content, white papers, case studies, research papers, webinars, training, and up-to-date scientific medical resources.

Personalised content based on your areas of interest

Connect and stay up-to-date with peers in your area of speciality and topics of interest through free events and leadership forums.

Please sign in to continue and read the full article

Please sign up to continue reading the full article.

We respect your privacy and will not share your information with any 3rd parties.

Topical guides written specifically for patients

Unlimited access to the latest patient guide guides and resources. Share content with your patients with easy-to-use online tools.

Please complete your profile to read the content.

Your profile is not validated yet. Please verify your inbox.

Restricted Access

We can't find the page you're looking for

You are going to a website that is not operated by Sanofi. Sanofi has no control over the content or availability of linked sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them. Please ensure that you read the legal and privacy policy sections of any third-party site to which you link.

You are about to leave Sanofi Campus website.

You are now leaving this site to visit a partner website.

Thank you for visiting COPD Sanofi Campus.

Welcome to COPD Sanofi Campus.

Welcome to COPD Sanofi Campus

Welcome to CSU Sanofi Campus

Please refresh the page to access the content

Sorry, something went wrong

The page you are looking for may be under maintenance, or the link may be incorrect.

Sorry, we can't find this page

You are going to a website that is not operated by Sanofi or a Sanofi website where the terms of use may differ. For external websites, Sanofi has no control over the content or availability of linked sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them. Please ensure that you read the legal and privacy policy sections of any third-party or Sanofi sites.

You are about to leave Sanofi campus website.

You are about to leave Campus.sanofi/uk.

Images from <a>iStockphoto.com</a>, Fotolia.de, <c>gettyimages.de</c>, <d>pexels.com</d> and <e>photocase.de</e> were used for our websites.

Thank you for registering. Before we get started, we need to confirm your email address to ensure that we have the correct information.

Please follow these steps to complete your registration:

Would you like to receive future text messages about Beyfortus updates?

Sanofi is here to help support your patients, their families, and caregivers. For more information regarding Beyfortus®, call <a.callPhoneNumberBeyfortus>1-855-BEYFORTUS (1-855-239-3678)</a.callPhoneNumberBeyfortus> or sign up below to receive the latest updates via email or text. All fields are required.

Would you like to learn more about Beyfortus® (nirsevimab-alip) 50 mg and 100 mg injection? Leave us your contact details, and a Sanofi representative will be in touch. All fields are required.

Would you also like to receive future messages and updates about Beyfortus?

Do you want to participate in the Beyfortus Reservation Program?

What information are you interested in learning more about? (Optional)

Request a visit from your local ALPROLIX representative to learn more. Call <a.callPhoneNumberAltuviiio>1-800-745-4447</a.callPhoneNumberAltuviiio>, Option 5, or complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Request a visit from your local ALTUVIIIO representative to learn more. Call <a.callPhoneNumberAltuviiio>1-800-745-4447</a.callPhoneNumberAltuviiio>, Option 5, or complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Request a visit from your local QFITLIA representative to learn more. Call <a.callPhoneNumberAltuviiio>1-800-745-4447</a.callPhoneNumberAltuviiio>, Option 5, or complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Sign up to schedule an office visit with your ALPROLIX® Representative or receive updates about ALPROLIX. Please complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Sign up to schedule an office visit with your local Sanofi representative and/or to receive updates about Qfitlia. Please complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required (unless otherwise specified).

This site is intended for UK healthcare professionals only and contains information on Sanofi UK's medicines, educational resources and more. Please click the appropriate button below. By entering this site, you are confirming that you are a UK healthcare professional. This site contains promotional information. Please note that some of the content on the website is only relevant for HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

MAT-XU-2300297 (v6.0) - Date of Preparation: April 2024

Welcome to Sanofi Campus UK

This content is only available to registered users. Please sign in or register to view this content.

Please Sign In

Email verification

You're seeing a preview of the portal. Clear your cookies (by closing your browser window for example) to go back to public mode.

We've updated our privacy notice to better protect your data and enhance your experience. Please take a moment to review the changes by <privacyNewTab>clicking here</privacyNewTab>. Your privary matters for us. Please click on continue to confirm you have read the new privacy notice.

Privacy Notice Update

Communication consent

My Consent

Password

Confirm password

{resultsCount, plural, one {result} other {results}}

Please sign in to access to the results

You need to sign-in to your account in order to access medical content.

To access the results, please register in under 1 minute

You are now leaving the Sanofi content section of our site and entering the external medical bibliographic search content section.

You are entering to the External Scientific Content Site

You are now leaving the external medical bibliographic search section of our site and entering the Sanofi content section.

Latest Resources

Ways to Order

Health System Collaboration Portal

Formulary and Service Support

Let’s Be Sustainable

Let’s be Collaborative and Transformative

MenQuadfi▼ (Meningococcal Group A, C, W and Y Conjugate Vaccine) Support resources

Diagnostic Algorithms for Gaucher disease

Downloadable PDF: Signs & Symptoms of Gaucher disease

Diabetes patient support

Latest Resources

Ways to Order

Health System Collaboration Portal

Formulary and Service Support

Let’s Be Sustainable

Let’s be Collaborative​ and Transformative

MenQuadfi▼ (Meningococcal Group A, C, W and Y Conjugate Vaccine) Support resources

Diagnostic Algorithms for Gaucher disease

Downloadable PDF: Signs & Symptoms of Gaucher disease

Diabetes patient support

Let’s be Collaborative and Transformative